Corrigendum to Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram [Ann Oncol 26, (2015) 1930-1935] doi: 10.1093/annonc/mdv279;Survival after resection of perihilar cholangiocarcinoma-Development and external validation of a prognostic nomogram

Annals of Oncology

Volumn 26, Issue 9, 2015, Pages 1930-1935

  Groot Koerkamp, Bas ^a,b   Wiggers, J K ^a,c   Gonen, M ^a   Doussot, A ^a   Allen, P J ^a   Besselink, M G H ^c   Blumgart, L H ^a   Busch, O R C ^c   D'Angelica, M I ^a   DeMatteo, R P ^a   Gouma, D J ^c   Kingham, T P ^a   van Gulik, T M ^c   Jarnagin, W R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Cholangiocarcinoma; Nomogram; Prognostic model; Survival

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT DRAINAGE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; FEMALE; HEMIHEPATECTOMY; HUMAN; LIVER RESECTION; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; NOMOGRAM; OVERALL SURVIVAL; PERIHILAR CHOLANGIOCARCINOMA; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; VALIDATION STUDY; VERY ELDERLY; ALGORITHM; CANCER STAGING; KLATSKIN TUMOR; MIDDLE AGED; MORTALITY; PROGNOSIS; THEORETICAL MODEL;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; FEMALE; HUMANS; KLATSKIN TUMOR; MALE; MIDDLE AGED; MODELS, THEORETICAL; NEOPLASM STAGING; NOMOGRAMS; PROGNOSIS;

EID: 84941632001     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdw063     Document Type: Erratum

References (25)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014; 64: 9-29.
2. Jarnagin WR, Fong Y, DeMatteo RP et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001; 234: 507-517; discussion 517-509.
3. Popescu I, Dumitrascu T. Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making. Langenbecks Arch Surg 2014; 399: 693-705.
4. Groot Koerkamp B, Wiggers JK, Allen PJ et al. American Joint Committee on Cancer staging for resected perihilar cholangiocarcinoma: a comparison of the 6th and 7th editions. HPB (Oxford) 2014; 16: 1074-1082.
5. Nuzzo G, Giuliante F, Ardito F et al. Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients. Arch Surg 2012; 147: 26-34.
6. Lee SG, Song GW, Hwang S et al. Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience. J Hepatobiliary Pancreat Sci 2010; 17: 476-489.
7. Furusawa N, Kobayashi A, Yokoyama T et al. Surgical treatment of 144 cases of hilar cholangiocarcinoma without liver-related mortality. World J Surg 2014; 38: 1164-1176.
8. Klempnauer J, Ridder GJ, von Wasielewski R et al. Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol 1997; 15: 947-954.
9. Song SC, Choi DW, Kow AW et al. Surgical outcomes of 230 resected hilar cholangiocarcinoma in a single centre. ANZ J Surg 2013; 83: 268-274.
10. Ito K, Ito H, Allen PJ et al. Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma. Ann Surg 2010; 251: 675-681.
11. Endo I, House MG, Klimstra DS et al. Clinical significance of intraoperative bile duct margin assessment for hilar cholangiocarcinoma. Ann Surg Oncol 2008; 15: 2104-2112.
12. Wang Y, Li J, Xia Y et al. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol 2013; 31: 1188-1195.
13. Gerhards MF, Gonzalez DG, ten Hoopen-Neumann H et al. Prevention of implantation metastases after resection of proximal bile duct tumours with preoperative low dose radiation therapy. Eur J Surg Oncol 2000; 26: 480-485.
14. Aoba T, Ebata T, Yokoyama Y et al. Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes. Ann Surg 2013; 257: 718-725.
15. Guglielmi A, Ruzzenente A, Campagnaro T et al. Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma. J Gastrointest Surg 2013; 17: 1917-1928.
16. National Comprehensive Cancer Network. Hepatobiliary Cancers, in version 2, 2nd edition. 2015. http://www.nccn.org (27 July 2015, date last accessed).
17. Valle J, Wasan H, Palmer DH et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 2010; 362: 1273-1281.
18. Horgan AM, Amir E, Walter T, Knox JJ. Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. J Clin Oncol 2012; 30: 1934-1940.
19. Kaiser GM, Paul A, Sgourakis G et al. Novel prognostic scoring system after surgery for Klatskin tumor. Am Surg 2013; 79: 90-95.
20. van der Gaag NA, Kloek JJ, de Bakker JK et al. Survival analysis and prognostic nomogram for patients undergoing resection of extrahepatic cholangiocarcinoma. Ann Oncol 2012; 23: 2642-2649.
21. Song C, Kim K, Chie EK et al. Nomogram prediction of survival and recurrence in patients with extrahepatic bile duct cancer undergoing curative resection followed by adjuvant chemoradiation therapy. Int J Radiat Oncol Biol Phys 2013; 87: 499-504.
22. Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 1975; 140: 170-178.
23. Gold JS, Gonen M, Gutierrez A et al. Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis. Lancet Oncol 2009; 10: 1045-1052.
24. Wang SJ, Lemieux A, Kalpathy-Cramer J et al. Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer. J Clin Oncol 2011; 29: 4627-4632.
25. Kow AW, Wook CD, Song SC et al. Role of caudate lobectomy in type III A and III B hilar cholangiocarcinoma: a 15-year experience in a tertiary institution. World J Surg 2012; 36: 1112-1121.